Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6B1 pseudogene 6 (COX6B1P6) is a processed, noncoding pseudogene in the human genome. It arose from the retrotransposition of the mRNA encoding the functional cytochrome c oxidase subunit VIb-1, acquiring mutations that prevent it from coding a functional protein[1]. Such pseudogenes are evolutionarily related to their parent gene and may serve as a molecular record of gene evolution. While some pseudogenes display regulatory capacity, such as generating noncoding RNAs that modulate parental gene expression or acting as competing endogenous RNAs, there is no published evidence that COX6B1P6 has such roles. It is not considered a drug target, nor do existing data link it to human pathology[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6B1 pseudogene 6 (COX6B1P6).